SecBot SecBot
6-K ·Filed Jul 20, 2026

BWAY

Brainsway Ltd.
NEUTRAL
Impact 4/10
Horizonmonths Processed3mo ago SEC0001171843-26-004757
Notable filing: 6-K
Actionable Insight • Neutral

The $3M investment is too small to move the stock on its own, but it signals continued execution of BrainsWay's strategy to vertically integrate into provider networks. Monitor for future similar investments or potential revenue-sharing arrangements that could expand Deep TMS utilization. The prior 20-F showed strong 27% revenue growth, so this investment aligns with a growth narrative but lacks near-term financial impact.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$16.50
T+0 close · Jul 20, 2026 · via day close
Latest settled
−27.76%
T+60 · $11.92
Vs SPY
−32.60%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 20 $16.50entry
  2. T+1 · 4mo ago −2.12%α −2.96% · $16.15
  3. T+5 · 4mo ago −3.21%α −2.79% · $15.97
  4. T+20 · 3mo ago −6.12%α −10.24% · $15.49
  5. T+60 · 5w ago −27.76%α −32.60% · $11.92
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BrainsWay announced a $3 million minority equity investment in Radial Health, Inc., a management services organization supporting Brain Medicine clinics, as part of Radial's Series A financing. The investment is a continuation of BrainsWay's strategy to take minority stakes in high-performing mental health provider networks to expand awareness and access to its Deep TMS technology. The $3 million amount is small relative to BrainsWay's $630M market cap (0.48%), making this a modest strategic move rather than a material financial event.

Key Facts

  • BrainsWay invested $3 million in Radial Health, Inc. as part of its Series A financing.
  • The investment is a minority equity stake, with BrainsWay joining investors including General Catalyst, Floating Point Capital, and others.
  • Radial specializes in clinical infrastructure, reimbursement tools, and AI-guided decision support for Brain Medicine treatments, including Deep TMS.
  • This is the latest in a series of minority equity investments by BrainsWay in mental health provider networks.

Financial Impact

$3 million minority investment, representing ~0.48% of BrainsWay's market cap; no revenue or earnings impact disclosed.

cashstrategic investments

Risk Factors

  • Minority stake may not yield meaningful returns or strategic benefits.
  • Investment could divert management attention from core operations.
  • Radial's success depends on M&A and scaling, which carries execution risk.

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-004757
Document: f6k_071626.htm0001171843-26-004757
Document: 0001171843-26-004757-index-headers.html0001171843-26-004757
Document: 0001171843-26-004757-index.html0001171843-26-004757
Document: 0001171843-26-004757.txt0001171843-26-004757

US Market Status

Market Closed · Opens Wed (10h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026